Safety and the Efficacy of MesenCure for the Treatment of Pulmonary Manifestations of COVID-19

NCT04716998 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
50
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

BonusBio Group Ltd